A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure.
CONCLUSION: Effectiveness and safety of onabotulinumtoxinA in Korea in a real-world setting was demonstrated.
PMID: 30943692 [PubMed]
Source: International Neurourology Journal - Category: Urology & Nephrology Tags: Int Neurourol J Source Type: research
More News: Brain | Drugs & Pharmacology | Incontinence | Neurology | Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology